PainTEQ

Mar 20, 2024

Outcomes of a Posterior Approach to SI Joint Fusion with LinQ(TM) Reflect Clinical Efficacy and Durability at 12 Months

Jan 18, 2024

PainTEQ Announces Successful Completion of First In-Office LinQ Procedure Under New CMS Billing Code

Nov 04, 2020

PainTEQ announces national headquarter office in Tampa

Aug 18, 2020

Shanth Thiyagalingam joins PainTEQ to lead commercialization of novel SI joint pain therapy

Aug 11, 2020

PainTEQ Begins Novel Biomechanical Study on SI Joint Fusion

Jul 21, 2020

PainTEQ Announces Landmark SI Joint Fusion Study

Jul 01, 2020

Michael Enxing joins PainTEQ Board of Directors